Jeffrey J. Swigris
About
Jeffrey J. Swigris is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology.
According to data from OpenAlex, Jeffrey J. Swigris has authored 103 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Pulmonary and Respiratory Medicine, 31 papers in Epidemiology and 27 papers in Physiology. Recurrent topics in Jeffrey J. Swigris's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (88 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (20 papers) and Sarcoidosis and Beryllium Toxicity Research (19 papers). Jeffrey J. Swigris is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (88 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (20 papers) and Sarcoidosis and Beryllium Toxicity Research (19 papers). Jeffrey J. Swigris collaborates with scholars based in United States, Italy and Germany. Jeffrey J. Swigris's co-authors include Kevin K. Brown, Talmadge E. King, Aryeh Fischer, Lisa Lancaster, Steven D. Nathan, Marilyn K. Glassberg, Paul W. Noble, David J. Lederer, Carlos A. Pereira and Ian Glaspole and has published in prestigious journals such as New England Journal of Medicine, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.
In The Last Decade
Jeffrey J. Swigris
98 papers receiving 7.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jeffrey J. Swigris United States | 39 | 6.6k | 2.5k | 1.5k | 1.2k | 1.1k | 103 | 7.7k | ||
| Mary E. Strek United States | 40 | 4.4k 0.7× | 1.9k 0.8× | 1.3k 0.8× | 777 0.6× | 1.0k 0.9× | 124 | 5.5k | ||
| Imre Noth United States | 41 | 5.3k 0.8× | 2.0k 0.8× | 937 0.6× | 757 0.6× | 909 0.8× | 143 | 6.1k | ||
| Marilyn K. Glassberg United States | 32 | 6.2k 0.9× | 2.4k 1.0× | 778 0.5× | 903 0.8× | 539 0.5× | 95 | 7.6k | ||
| Jeffrey J. Swigris United States | 33 | 4.6k 0.7× | 1.8k 0.7× | 840 0.6× | 470 0.4× | 769 0.7× | 77 | 5.2k | ||
| Wim Wuyts Belgium | 39 | 4.1k 0.6× | 1.6k 0.7× | 642 0.4× | 412 0.3× | 493 0.4× | 199 | 5.3k | ||
| Elyse E. Lower United States | 49 | 4.7k 0.7× | 4.7k 1.9× | 1.1k 0.7× | 720 0.6× | 328 0.3× | 164 | 7.0k | ||
| Francesco Bonella Germany | 41 | 3.9k 0.6× | 1.3k 0.5× | 576 0.4× | 422 0.4× | 360 0.3× | 212 | 4.5k | ||
| Kay Tetzlaff Germany | 24 | 4.1k 0.6× | 2.3k 0.9× | 624 0.4× | 378 0.3× | 1.1k 1.0× | 77 | 4.9k | ||
| Lorraine Harper United Kingdom | 48 | 5.7k 0.9× | 1.7k 0.7× | 527 0.3× | 2.7k 2.2× | 450 0.4× | 192 | 8.3k | ||
| T. Papo France | 44 | 1.5k 0.2× | 875 0.4× | 990 0.6× | 2.1k 1.7× | 624 0.6× | 245 | 6.4k |
Countries citing papers authored by Jeffrey J. Swigris
Since
Specialization
Citations
This map shows the geographic impact of Jeffrey J. Swigris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey J. Swigris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey J. Swigris more than expected).
Fields of papers citing papers by Jeffrey J. Swigris
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jeffrey J. Swigris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey J. Swigris. The network helps show where Jeffrey J. Swigris may publish in the future.
Co-authorship network of co-authors of Jeffrey J. Swigris
This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey J. Swigris. A scholar is included among the top collaborators of Jeffrey J. Swigris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey J. Swigris. Jeffrey J. Swigris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Koslow, Matthew, David Baraghoshi, Jeffrey J. Swigris, et al.. (2025). One-Year Change in Quantitative Computed Tomography Is Associated with Meaningful Outcomes in Fibrotic Lung Disease. American Journal of Respiratory and Critical Care Medicine. 211(10). 1775–1784.
2.
Chan, Sock Hoai, et al.. (2024). First ever characterisation of the effects of short telomeres in a Singapore interstitial lung disease cohort. Respiratory Investigation. 62(3). 348–355.
3.
Humphries, Stephen M., David Baraghoshi, Matthew Strand, et al.. (2024). Deep Learning Classification of Usual Interstitial Pneumonia Predicts Outcomes. American Journal of Respiratory and Critical Care Medicine. 209(9). 1121–1131.
4.
Oh, Andrea, David A. Lynch, Jeffrey J. Swigris, et al.. (2023). Deep Learning–Based Fibrosis Extent on Computed Tomography Predicts Outcome of Fibrosing Interstitial Lung Disease Independent of Visually Assessed Computed Tomography Pattern. Annals of the American Thoracic Society. 21(2). 218–227.
5.
Swigris, Jeffrey J., Sonye K. Danoff, Paul F. Dellaripa, Tracy J. Doyle, & Joshua J. Solomon. (2023). Reliability and responsiveness of the D12 and validity of its scores as a measure of dyspnoea severity in patients with rheumatoid arthritis-related interstitial lung disease. BMJ Open Respiratory Research. 10(1). e001872–e001872.
6.
Swigris, Jeffrey J., et al.. (2022). Responsiveness and meaningful change thresholds of the Living with Pulmonary Fibrosis (L-PF) questionnaire Dyspnoea and Cough scores in patients with progressive fibrosing interstitial lung diseases. BMJ Open Respiratory Research. 9(1). e001167–e001167.
7.
Pérez, Evans R. Fernández, James Crooks, Jeffrey J. Swigris, et al.. (2021). Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis. ERJ Open Research. 7(2). 54–2021.
8.
Ley, Brett, Jeffrey J. Swigris, John L. Stauffer, et al.. (2017). Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 196(6). 756–761.
9.
Kreuter, Michael, Jeffrey J. Swigris, David Pittrow, et al.. (2017). Quality Of Life (qol) Trajectory In Patients With Idiopathic Pulmonary Fibrosis (ipf): Longitudinal Qol Assessment Of The Insights-Ipf Registry. American Journal of Respiratory and Critical Care Medicine.
10.
Yunt, Zulma X., Jonathan H. Chung, Stephen Hobbs, et al.. (2017). High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival. Respiratory Medicine. 126. 100–104.
11.
Fischer, Aryeh, Amanda M. Kong, Jeffrey J. Swigris, Ashley L. Cole, & Karina Raimundo. (2017). All-cause Healthcare Costs and Mortality in Patients with Systemic Sclerosis with Lung Involvement. The Journal of Rheumatology. 45(2). 235–241.
12.
Chung, Jonathan H., Jeffrey J. Swigris, Joshua J. Solomon, et al.. (2016). Clinical Predictors of a Diagnosis of Common Variable Immunodeficiency-related Granulomatous-Lymphocytic Interstitial Lung Disease. Annals of the American Thoracic Society. 13(7). 1042–1049.
13.
Swigris, Jeffrey J., Amy L. Olson, & Kevin K. Brown. (2016). Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis. Patient Related Outcome Measures. 7. 29–29.
14.
Cao, Mengshu, Frederick S. Wamboldt, Kevin K. Brown, et al.. (2015). Supplemental oxygen users with pulmonary fibrosis perceive greater dyspnea than oxygen non-users. Multidisciplinary Respiratory Medicine. 10.
15.
Baird, Susan, et al.. (2014). Protocol for a Mixed-Methods Study of Supplemental Oxygen in Pulmonary Fibrosis. CHEST Journal. 146(4). 370A–370A.
16.
Pérez, Evans R. Fernández, Kevin K. Brown, Tristan J. Huie, et al.. (2013). FEV1 over time in patients with connective tissue disease-related bronchiolitis. Respiratory Medicine. 107(6). 883–889.
17.
Solomon, Joshua J., et al.. (2013). Hypersplenism and Polyarthritis Are Strong Risk Factors for Common Variable Immunodeficiency Related Granulomatous-Lymphocytic Interstitial Lung Disease. CHEST Journal. 144(4). 469A–469A.
18.
Olson, Amy L., Jeffrey J. Swigris, David Sprunger, et al.. (2010). Rheumatoid Arthritis–Interstitial Lung Disease–associated Mortality. American Journal of Respiratory and Critical Care Medicine. 183(3). 372–378.
19.
Swigris, Jeffrey J., Amy L. Olson, Aryeh Fischer, et al.. (2006). Mycophenolate Mofetil Is Safe, Well Tolerated, and Preserves Lung Function in Patients With Connective Tissue Disease-Related Interstitial Lung Disease. CHEST Journal. 130(1). 30–36.
20.
Swigris, Jeffrey J., Ware G. Kuschner, Jennifer L. Kelsey, & Michael K. Gould. (2005). Idiopathic Pulmonary Fibrosis. CHEST Journal. 127(1). 275–283.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Mary E. Strek Breakdown of academic impact, for papers by Imre Noth Breakdown of academic impact, for papers by Marilyn K. Glassberg Breakdown of academic impact, for papers by Jeffrey J. Swigris Breakdown of academic impact, for papers by Wim Wuyts Breakdown of academic impact, for papers by Elyse E. Lower Breakdown of academic impact, for papers by Francesco Bonella Breakdown of academic impact, for papers by Kay Tetzlaff Breakdown of academic impact, for papers by Lorraine Harper Breakdown of academic impact, for papers by T. Papo